Results for femorali translation from Maltese to English

kondil femorali
femoral condyle

bmd għonq femorali
femoral neck bmd

trombożi tal- arterja femorali sindrom ta’ nixxija kapillari
femoral artery thrombosis capillary leak syndrome

trombożi ta ’ l- arterja femorali sindrom ta ’ nixxija kapillari
femoral artery thrombosis capillary leak syndrome

allinjament ħażin: il-ġog tibjo-femorali għandu jkun allinjat sew.
malalignment: the tibio-femoral joint should be properly aligned.

pazjenti bi plakka tat-tkabbir epifiseali femorali li għadha mhix magħluqa għal kollox.
patients with femoral epiphyseal growth plate that is not fully closed

Żidiet simili seħħew fl-għonq femorali, it-trokanter, u l-intertrokanter.
similar increases occurred at the femoral neck, trochanter, and intertrochanter.

Ħu ħsieb biex tiżgura li l-ħajt anterjuri biss ta’ l- arterja femorali jkun imtaqqab.
take care to ensure that only the anterior wall of the femoral artery is punctured.

id-difetti kienu fil-qarquċa tal-kondil femorali u jvarjaw minn 1 sa 5 cm2 fid-daqs.
the defects were on the femoral condyle and were between 1 and 5 cm2 in size.

chondrocelect jintuża biex isewwi difett singolu sintomatiku tal-qarquċa fil-kondil femorali tal-irkoppa fl-adulti.
chondrocelect is used to repair single symptomatic cartilage defects in the femoral condyle of the knee in adults.

chondrocelect mhuwiex irrakkomandat għat-tiswija ta’ difetti tal-qarquċa f’postijiet oħra ħlief il- kondil femorali.
chondrocelect is not recommended for the repair of cartilage defects in other locations than the femoral condyle.

intwera tnaqqis fir-riskju ta’ ksur vertebrali, l-effikaċja fuq il-ksur tal-għonq femorali għadha ma ġietx stabbilita.
a reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.

il-kura b’aclasta rriżultat f’żieda fil-bmd ta’ 5.4% fil-ġenb totali u ta’ 4.3% fl-għonq femorali fuq perjodu ta’ 24 xahar meta mqabbel mal-plaċebo.
treatment with aclasta resulted in an increase in bmd of 5.4% at the total hip and 4.3% at the femoral neck over 24 months as compared to placebo.